A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
Stopped early · Phase 3
Conditions studied: Candidiasis, Invasive, Candidemia
In brief
This is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis included candidemia. Subjects will receive intravenous echinocandin followed by oral ibrexafungerp (SCY-078) vs intravenous echinocandin followed by oral fluconazole.
Key facts
- Study ID
- NCT05178862
- Run by
- Scynexis, Inc.
- People needed
- 68
- Starts
- 2022-08-03
- Expected to finish
- 2025-12-16
- Last updated by the study team
- 2025-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center-Tucson — Tucson, Arizona, United States
- UC Davis Medical Center — Sacramento, California, United States
- UCSF School of Medicine — San Francisco, California, United States
- University of Colorado Anschutz Medical Campus — Denver, Colorado, United States
- Augusta University Medical Center — Augusta, Georgia, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Ochsner Medical Center — New Orleans, Louisiana, United States
- LSU Health Sciences Center — Shreveport, Louisiana, United States
- University of Maryland Medical Center — Baltimore, Maryland, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- University of Michigan Hospital — Ann Arbor, Michigan, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- University of Minnesota Medical Center — Minneapolis, Minnesota, United States
- Mayo Clinic - Rochester — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Mercury Street Medical Group, PLLC — Butte, Montana, United States
- Duke University — Durham, North Carolina, United States
- University of Pennsylvania School of Medicine — Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- The Miriam Hospital — Providence, Rhode Island, United States
- Houston Methodist Hospital — Houston, Texas, United States
- University of Texas Health Science Center at Houston — Houston, Texas, United States
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- University of Alabama at Birmingham School of Medicine — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.